Combined with our research, it is speculated that inhibiting the expression of FAM84B can affect the AKT/GSK-3β/β-catenin pathway to regulate the key proteins of the cell cycle, induce cell cycle arrest, and then inhibit the malignant proliferation of glioma cells. The gene discussed is GSK3B; the disease is central nervous system cancer.